LIVTENCITY

This brand name is authorized in Austria, Canada, Spain, France, Croatia, Israel, Italy, Lithuania, Romania, United States

Active ingredients

The drug LIVTENCITY contains one active pharmaceutical ingredient (API):

1 Maribavir UNII PTB4X93HE1 - MARIBAVIR

Maribavir is a competitive inhibitor of the UL97 protein kinase. UL97 inhibition occurs at the viral DNA replication phase, inhibiting UL97 serine/threonine kinase by competitively inhibiting the binding of ATP to the kinase ATP-binding site, without affecting the concatemer maturation process, abolishing phosphotransferase inhibiting CMV DNA replication and maturation, CMV DNA encapsidation, and CMV DNA nuclear egress. Read about Maribavir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LIVTENCITY Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AX10		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02530740
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1221672002
Country: FR	Base de données publique des médicaments	Identifier(s): 66919901
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9220
Country: IT	Agenzia del Farmaco	Identifier(s): 050317015, 050317027, 050317039
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1095951, 1095952
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69408001, W69408002
Country: US	FDA, National Drug Code	Identifier(s): 64764-800